Home/Filings/4/0001209191-17-050211
4//SEC Filing

Ware J. Anthony 4

Accession 0001209191-17-050211

CIK 0001370053other

Filed

Aug 23, 8:00 PM ET

Accepted

Aug 24, 6:41 PM ET

Size

7.8 KB

Accession

0001209191-17-050211

Insider Transaction Report

Form 4
Period: 2017-08-22
Transactions
  • Award

    Director Stock Option (right to buy)

    2017-08-22+28,57128,571 total
    Exercise: $21.45Exp: 2027-08-21Common Stock (28,571 underlying)
  • Award

    Director Stock Option (right to buy)

    2017-08-22+10,69410,694 total
    Exercise: $21.45Exp: 2027-08-21Common Stock (10,694 underlying)
Footnotes (2)
  • [F1]The stock option vests and becomes exercisable in 36 equal monthly installments beginning on September 22, 2017, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
  • [F2]The stock option vests and becomes fully exercisable on May 30, 2018.

Issuer

ANAPTYSBIO INC

CIK 0001370053

Entity typeother

Related Parties

1
  • filerCIK 0001715429

Filing Metadata

Form type
4
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 6:41 PM ET
Size
7.8 KB